LZTFL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.724800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.219200E-01
Normal-vs-Stage2
3.551000E-01
Normal-vs-Stage3
1.643560E-02
Normal-vs-Stage4
7.274200E-01
Stage1-vs-Stage2
1.447790E-01
Stage1-vs-Stage3
1.957560E-02
Stage1-vs-Stage4
7.978800E-01
Stage2-vs-Stage3
1.180490E-04
Stage2-vs-Stage4
1.222560E-01
Stage3-vs-Stage4
3.611700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.965200E-01
Normal-vs-AfricanAmerican
4.361200E-01
Normal-vs-Asian
3.730000E-01
Caucasian-vs-AfricanAmerican
8.553400E-01
Caucasian-vs-Asian
6.040400E-01
AfricanAmerican-vs-Asian
8.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.995200E-01
Normal-vs-Female
5.474000E-01
Male-vs-Female
9.047600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.381000E-01
Normal-vs-Age(41-60Yrs)
8.410400E-01
Normal-vs-Age(61-80Yrs)
5.170200E-01
Normal-vs-Age(81-100Yrs)
1.331610E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.486000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.667800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.611400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.956400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.176400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.419000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.613800E-01
Normal-vs-Daily Drinker
1.003990E-01
Normal-vs-Weekly Drinker
1.923780E-01
Normal-vs-Occasional Drinker
9.544600E-01
Normal-vs-Social Drinker
7.841400E-01
Non Drinker-vs-Daily Drinker
5.624800E-01
Non Drinker-vs-Weekly Drinker
8.443400E-01
Non Drinker-vs-Occasional Drinker
9.460000E-02
Non Drinker-vs-Social Drinker
3.125600E-01
Daily Drinker-vs-Weekly Drinker
7.430400E-01
Daily Drinker-vs-Occasional Drinker
1.888390E-02
Daily Drinker-vs-Social Drinker
1.716210E-01
Weekly Drinker-vs-Occasional Drinker
8.226100E-02
Weekly Drinker-vs-Social Drinker
2.811200E-01
Occasional Drinker-vs-Social Drinker
6.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.645400E-01
Normal-vs-Grade 2
7.902600E-01
Normal-vs-Grade 3
4.642000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.716800E-01
Grade 1-vs-Grade 3
3.953600E-01
Grade 1-vs-Grade 4
5.645400E-01
Grade 2-vs-Grade 3
9.839600E-01
Grade 2-vs-Grade 4
7.902600E-01
Grade 3-vs-Grade 4
4.642000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.859990E-01
Normal-vs-NonDiabetic
6.061400E-01
Diabetic-vs-NonDiabetic
1.315990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.298200E-02
Normal-vs-NoPancreatitis
5.777200E-01
Pancreatitis-vs-NoPancreatitis
5.480100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.921600E-01
Normal-vs-N1
3.406400E-01
N0-vs-N1
1.925840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.572000E-01
Normal-vs-TP53-NonMutant
9.220800E-01
TP53-Mutant-vs-TP53-NonMutant
2.835600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
